Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/08/2014CA2598216C Androgen receptor modulator compounds and methods
04/08/2014CA2593523C Treatment of drug-resistant proliferative disorders
04/08/2014CA2580811C Carbostyril compound
04/08/2014CA2572047C Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/08/2014CA2558219C Poorly water-soluble drug-containing solid formulation
04/08/2014CA2538315C Matrix metalloproteinase inhibitors
04/08/2014CA2524773C Particulate coformulations of active substances with excipients
04/08/2014CA2506310C New antagonist derivatives for the vitronectin receptor, their preparation method, their application as medication and the pharmaceutical compositions containing them
04/08/2014CA2494348C Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
04/08/2014CA2378402C Method of treating malignancies and viral infections and improving immune function with a dietary supplement
04/04/2014CA2800083A1 Integrated neuromodulation system for mood enhancement of a living human subject
04/03/2014WO2014052973A1 Methods of making silver nanoparticles and their applications
04/03/2014WO2014052935A2 Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease
04/03/2014WO2014052931A1 Human toll-like receptor inhibitors and methods of use thereof
04/03/2014WO2014052914A1 Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
04/03/2014WO2014052906A1 Dihydro-6-azaphenalene derivatives for the treatment of cns, oncological diseases and related disorders
04/03/2014WO2014052896A1 Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
04/03/2014WO2014052889A1 Anti-inflammatory agents
04/03/2014WO2014052880A1 Nutritional supplements for eye health and related methods
04/03/2014WO2014052859A1 Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
04/03/2014WO2014052849A1 Combination treatments for bipolar disorders
04/03/2014WO2014052837A1 Device and methods for sustained release of antipsychotic medications
04/03/2014WO2014052831A1 Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease
04/03/2014WO2014052828A1 Compositions and methods for modulating tlr4
04/03/2014WO2014052799A1 Tazobactam arginine antibiotic compositions
04/03/2014WO2014052780A2 Compositions and methods of use of an inappetance-controlling compound
04/03/2014WO2014052752A2 Use of isoflavones for treatment of food allergy
04/03/2014WO2014052739A2 System for interactively visualizing and evaluating user behavior and output
04/03/2014WO2014052699A1 Azaquinazoline inhibitors of atypical protein kinase c
04/03/2014WO2014052678A1 Apixaban liquid formulations
04/03/2014WO2014052669A1 Modulation of ire1
04/03/2014WO2014052659A1 Crystalline forms of neurotrophin mimetic compounds and their salts
04/03/2014WO2014052640A1 Novel ampk agonist compositions and methods of use
04/03/2014WO2014052638A1 Esters and malonates of sate prodrugs
04/03/2014WO2014052625A1 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
04/03/2014WO2014052619A1 Piperidine derivatives and compositions as modulators of gpr119 activity
04/03/2014WO2014052605A1 Compounds for the treatment and prevention of retroviral infections
04/03/2014WO2014052583A1 Compounds for the treatment of obesity and methods of use thereof
04/03/2014WO2014052566A1 Novel compounds that are erk inhibitors
04/03/2014WO2014052563A2 Novel compounds that are erk inhibitors
04/03/2014WO2014052555A1 Compositions and methods for treating hepatitis b
04/03/2014WO2014052550A1 Use of parp inhibitors to treat breast cancer
04/03/2014WO2014052454A1 Imaging agents
04/03/2014WO2014052427A1 D-methadone for the treatment of psychiatric symptoms
04/03/2014WO2014052398A1 Inhibitor of beta-secretase
04/03/2014WO2014052379A1 Substituted cyclopropyl compounds
04/03/2014WO2014052365A1 Multiple kinase pathway inhibitors
04/03/2014WO2014052313A1 Topical ketoprofen composition
04/03/2014WO2014052237A1 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
04/03/2014WO2014052225A1 Composition for prostatic hyperplasia and prostate cancer
04/03/2014WO2014052195A2 Peelable film-forming compositions and methods of using the same
04/03/2014WO2014052171A1 Crystalline form of a reverse transcriptase inhibitor
04/03/2014WO2014051939A1 Phenicol antibacterial agents
04/03/2014WO2014051698A1 Fused heterocyclic compounds as selective bmp inhibitors
04/03/2014WO2014051654A2 Bicyclic oxa-lactam kinase inhibitors
04/03/2014WO2014051532A1 Pharmaceutical tablet formulations comprising cefdinir
04/03/2014WO2014051519A1 Telomerase inhibitors for use in therapy
04/03/2014WO2014051443A1 Method for producing extended-release potassium citrate wax matrix tablet
04/03/2014WO2014051440A1 Ectoparasitic treatment method and composition
04/03/2014WO2014051398A1 Pharmaceutical composition comprising acecainide or derivative thereof for preventing or treating diseases associated with muscular weakness
04/03/2014WO2014051388A1 Composition comprising sulfamide derivative having adamantyl group as active ingredient for preventing or treating brain diseases or ischemic heart diseases
04/03/2014WO2014051375A1 Triiodinated compound comprising phosphate and x-ray contrast media comprising same
04/03/2014WO2014051359A1 Pharmaceutical composition comprising neferine as active ingredient for preventing or treating hepatoma
04/03/2014WO2014051163A1 Pharmaceutical composition comprising rebamipide
04/03/2014WO2014051128A1 Transdermal patch
04/03/2014WO2014051113A1 Vegfc production promoter
04/03/2014WO2014051100A1 Anti-inflammatory agent
04/03/2014WO2014051056A1 Crystals of glycine derivative and pharmaceutical use thereof
04/03/2014WO2014051055A1 Quinuclidine urea derivatives and medicinal use thereof
04/03/2014WO2014051025A1 Anagliptin-containing solid preparation
04/03/2014WO2014051024A1 Anagliptin-containing drug composition
04/03/2014WO2014051023A1 Anagliptin-containing preparation
04/03/2014WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same
04/03/2014WO2014050910A1 Process for producing solid particles
04/03/2014WO2014050874A1 Novel crystalline form of rosuvastatin calcium and production method therefor
04/03/2014WO2014050781A1 Ret inhibitor
04/03/2014WO2014050779A1 Combination of gsk3 inhibitor and anti-dr5 antibody
04/03/2014WO2014050717A1 Skin condition amelioration agent
04/03/2014WO2014050692A1 Composition for reducing new-onset diabetes
04/03/2014WO2014050509A1 Liposome and liposome preparation
04/03/2014WO2014050390A1 Composition for food and fat absorption inhibitor
04/03/2014WO2014050144A1 Dentinal tubule blocking agent
04/03/2014WO2014050134A1 Therapeutic agent for dyslipidemia
04/03/2014WO2014050107A1 Crystalline polymorphic form of ulipristal acetate
04/03/2014WO2014050106A1 Crystalline polymorphic form of ulipristal acetate
04/03/2014WO2014050105A1 Amorphous ulipristal acetate
04/03/2014WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same
04/03/2014WO2014049841A1 Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
04/03/2014WO2014049619A1 Cancer chemotherapeutic agent/formulation, manufacture and use thereof
04/03/2014WO2014049578A1 New anti-invasive compounds
04/03/2014WO2014049549A1 Combination therapy using belinostat and trabectedin
04/03/2014WO2014049515A1 Pyrrolidine substituted flavones for treatment of renal cystic diseases
04/03/2014WO2014049514A1 Compounds for use in gastric complication
04/03/2014WO2014049471A1 Compositions and methods for the treatment of ventricular arrhythmias and cardiovascular diseases
04/03/2014WO2014049397A1 Synergic composition of nitazoxanide and mebendazole, methods for the preparation thereof, and use of said composition for the treatment of human parasitosis
04/03/2014WO2014049366A1 Treatment of wolfram syndrome-related neurodegeneration
04/03/2014WO2014049364A1 Indole derivatives
04/03/2014WO2014049356A1 Erythromycin ketolide derivatives bearing c-10 modifications
04/03/2014WO2014049351A1 Calcium/cation-sensing receptor (casr) antagonist like nps89636 for use in treating inflammatory lung disorders (asthma or copd)
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 7860